25th November
2024
Benchmark Holdings
plc
("Benchmark" or "the
Company")
Notice of Q4 and Full Year
Results
Webcast for analysts and
institutional investors
Equity Development webcast
for retail investors
Benchmark Holdings plc (AIM: BMK, Euronext
Growth Oslo: BMK), the aquaculture biotechnology business, will
announce its Q4 and Full Year results, for the 12 month period
ended 30 September 2024, on 12th December
2024.
Presentation
for analysts and institutional investors at 08:00 UK
time
Trond Williksen, Chief Executive Officer and
Septima Maguire, Chief Financial Officer will host a presentation
for analysts and institutional investors on the day at 08:00 UK
time (09:00 CET).
The presentation will be held in person at
Haakon Vlls Gate 2, Oslo, Norway. To register your interest, please
contact benchmark@mhpgroup.com
A live webcast of the presentation will be
available for analysts and investors to join remotely at the
following link: Benchmark
Holdings Webcast
Equity
Development webcast for retail investors at 11:00 UK
time
Trond Williksen, Chief Executive Officer and
Septima Maguire, Chief Financial Officer will host a second webcast
for retail investors and wealth managers at 11:00 UK time (12:00
CET). The webcast is open to all existing and potential
shareholders.
To register please visit:
https://www.equitydevelopment.co.uk/news-and-events/benchmark-investor-presentation-12december2024
Enquiries
For further information, please
contact:
|
|
Benchmark Holdings plc
|
benchmark@mhpgroup.com
|
Trond Williksen, CEO
|
|
Septima Maguire, CFO
|
|
Ivonne Cantu, Investor Relations
|
|
|
|
|
|
Deutsche Numis (Nominated Adviser and
Broker)
|
Tel: 020 7260 1000
|
Freddie Barnfield, Duncan Monteith, Sher
Shah
|
|
|
|
MHP
|
Tel: +447890 952 661
|
Katie Hunt, Reg Hoare, Samuel Garner
|
benchmark@mhpgroup.com
|
Equity Development
Hannah Crowe
|
Tel: 020 7065 2692
|
|
|
About
Benchmark
Benchmark is a leading aquaculture
biotechnology company. Benchmark's mission is to enable aquaculture
producers to improve their sustainability and
profitability.
We bring together biology and technology to
develop innovative products and solutions which improve yield,
quality and animal health and welfare for our customers. We do this
by improving the genetic make-up, health and nutrition of their
stock - from broodstock and hatchery through to nursery and grow
out.
Benchmark has a broad portfolio of products and
solutions, including salmon eggs, live feed (Artemia), specialist
diets and probiotics and sea lice treatments. Find out more
at www.benchmarkplc.com.